News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

|Articles|May 4, 2010

Answer: d. Stimulants

Stimulant use can worsen psychotic symptoms in persons with schizophrenia and schizoaffective disorder.

See how your colleagues answered

More on psychotic episodes

More on treatments for schizoaffective disorder

Poll Software Powered By WebsiteGear: Requires Javascript Enabled On Your Browser.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Latest CME

Managing Negative Symptoms of Schizophrenia: Can Prescription Digital Therapeutics Make an Impact?

Managing Negative Symptoms of Schizophrenia: Can Prescription Digital Therapeutics Make an Impact?

Michael Asbach, DMSc, PA-C; Erin Crown, MHS, PA-C, Psych-CAQ

Optimizing Care for Patients With Tardive Dyskinesia

Optimizing Care for Patients With Tardive Dyskinesia

Amber Hoberg, MSN, APRN, PMHNP-BC; Erin Crown, PA-C, Psych-CAQ

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

Jonathan Meyer, MD; Jacob Hanaie, PharmD, APh, BCPP; Sanjai Rao, MD, DFAPA

Trending on Psychiatric Times

Depression and Long COVID Outcomes in Women: New Data Analysis

Patterns of Propensity: A Review of Heinrichs’ How Psychiatrists Make Decisions

Investigational Psilocybin for PTSD and Ongoing Trials

In Memoriam: Elise Snyder, MD, A Legacy of Mentoring to Psychotherapists in China

Extension of Expanded Access Program for Zervimesine to Treat Dementia With Lewy Bodies